Catapres-TTS Articles

Addition of US firm Sciele helps boost Shionogi's R&D pipeline, meeting hears

6 April 2009

Japan stock market week to March 30, 2009

31 March 2009

Patient recruitment begins in Clonicel trial

5 November 2007

Massachusetts tracks pre-school children's psychiatric drug use

22 October 2007

Sciele takes $6M stake in Addrenex

23 July 2007

Advent of generic gabapentin impacts neuropathic pain market

18 July 2005

Pharmaceutical Resources to buy Kali

19 April 2004

Euro neuropathic pain products market to reach $1.7B by 2012: study

5 January 2004

Elan completes $102M product disposal

8 December 2003

Elan to sell pain products to aaiPharma

27 October 2003

Germany's Boehringer Ingelheim looking to Spiriva as growth driver

3 May 2001

Boeh Ingelheim restates independence strategy driven by innovative research

5 May 2000

Clintons act to cut Rxing for under-7s

22 March 2000

Clonidine poisoning in ADHD children

12 April 1999

Chiroscience Files Chirocaine NDA

30 April 1998

Strong Earnings Continue At Major US Drug Firms

10 February 1997

Russian Drug Output Fails To Meet Demand

27 January 1997

Fujisawa's cloidine hydrochloride

21 August 1995

EVENING PRIMROSE OIL AND THE MENOPAUSE

28 February 1994

Showing 1-19 of 19 articles

Go to beginningPrevious
  • 1
NextGo to end